Article ID Journal Published Year Pages File Type
4003154 American Journal of Ophthalmology 2011 10 Pages PDF
Abstract
Compared with PK, DALK has a favorable cost-effectiveness ratio and, resources permitting, should be considered as a first-line treatment for keratoconus. Additional studies are needed to confirm the expected advantages of DALK over PK when it comes to long-term graft failure rates.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , ,